CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Efficacy of once-daily, orally administered obefazimod in patients with moderately to severely active UC at weeks 8, 48, and 96 broken down by induction treatment dose
DOI 10.1055/s-0044-1789727
Bibliografische Angaben
Nachweis in CareLit
Autor:innenB. Siegmund, S. Danese, L. Peyrin-Biroulet, M. Dubinsky, P. Dulai, H. Tilg, S. Sloan, C. Rabbat, B. Sands, S. Vermeire
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2024
Jahrgang / SeitenJg. 62 · S. e626-e627
Kernaussage aus der Literatur
Abstract-Vorschau
Efficacy of once-daily, orally administered obefazimod in patients with moderately to severely active UC at weeks 8, 48, and 96 broken down by induction treatment dose
Zitieren
Zitierempfehlung
B. Siegmund, S. Danese, L. Peyrin-Biroulet, M. Dubinsky, P. Dulai, H. Tilg, S. Sloan, C. Rabbat, B. Sands, S. Vermeire (2024) Efficacy of once-daily, orally administered obefazimod in patients with moderately to severely active UC at weeks 8, 48, and 96 broken down by induction treatment dose. Zeitschrift für Gastroenterologie, 62 (09), e626-e627. https://doi.org/10.1055/s-0044-1789727
Mit CareLit weiterarbeiten